Published December 24, 2019 | Version 04
Other Restricted

Supplementary Material for the Article: A Dose-Escalation Study Demonstrates the Safety and Tolerability of Cellobiose in Healthy Subjects

Creators

  • 1. analyze & realize GmbH
  • 2. Savanna Ingredients GmbH
  • 3. Charité - Universitätsmedizin Berlin

Description

Table S1: Baseline characteristics – Bowel movements/day, BSFS types; Table S2: Changes in body weight and BMI; Table S3: GSRS dimensions during the study phases; Figure S1: Gastrointestinal adverse events after first intake with probable or possible connection to cellobiose intake.

 

Notes

Submitted 2019-12-24

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.